We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CDT Conduit Pharmaceuticals Inc

0.92 (19.66%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 127,683
Bid Price 4.39
Ask Price 5.60
News -
Day High 5.753


52 Week Range


Day Low 4.40
Company Name Stock Ticker Symbol Market Type
Conduit Pharmaceuticals Inc CDT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.92 19.66% 5.60 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.53 4.40 5.753 5.51 4.68
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,134 127,683 $ 5.01 $ 639,908 - 0.95 - 12.89
Last Trade Time Type Quantity Stock Price Currency
19:52:30 15 $ 5.11 USD

Conduit Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
252.75M 15.00M - 0 399k 0.03 633.46
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Conduit Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CDT Message Board. Create One! See More Posts on CDT Message Board See More Message Board Posts

Historical CDT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.806.501.714.56548,9493.80211.11%
1 Month1.476.501.063.80192,0254.13280.95%
3 Months12.6012.890.952.38559,892-7.00-55.56%
6 Months12.6012.890.952.38559,892-7.00-55.56%
1 Year12.6012.890.952.38559,892-7.00-55.56%
3 Years12.6012.890.952.38559,892-7.00-55.56%
5 Years12.6012.890.952.38559,892-7.00-55.56%

Conduit Pharmaceuticals Description

Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto¿s Thyroiditis. The Company¿s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto¿s Thyroiditis (HT) and Graves¿ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto¿s Thyroiditis and Graves¿ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI).

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |